Enrolling Now

Enrolling Now

Combined medications for those with

Type 2 Diabetes, Hypertension, and Cardiovascular Disease 

  • A study to evaluate the efficacy and safety of an investigational oral medication combined with an SGLT-2 inhibitor, compared with placebo and the SGLT-2 inhibitor, in adults with Type 2 diabetes, high blood pressure, and established cardiovascular disease.

    • Participants with medical history of hypertension and on active pharmacological treatment

    • Participants with medical history of T2DM and on active pharmacological treatment

    • Established CV disease and on active pharmacological treatment.

      • Established cardiovascular disease includes at least one of the following: coronary artery disease, or peripheral artery disease, or cerebrovascular disease 

    Further qualifications may apply.

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

Close-up of an elderly person's hand dispensing pills from an orange bottle onto the palm of their other hand on a gray cracked surface.

This study is run from our Manhattan office (235 East 38th Street).

Think you qualify? Fill out this form and a member of our medical research team will be in touch shortly with more information.